C
Claus Vogelmeier
Researcher at University of Marburg
Publications - 150
Citations - 30258
Claus Vogelmeier is an academic researcher from University of Marburg. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 36, co-authored 80 publications receiving 27094 citations. Previous affiliations of Claus Vogelmeier include University Hospital of Giessen and Marburg & Boston University.
Papers
More filters
Journal ArticleDOI
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo,Suzanne S. Hurd,Alvar Agusti,Paul W. Jones,Claus Vogelmeier,Antonio Anzueto,Peter J. Barnes,Leonardo M. Fabbri,Fernando J. Martinez,Masaharu Nishimura,Robert A. Stockley,Don D. Sin,Roberto Rodriguez-Roisin +12 more
TL;DR: It is recommended that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation.
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus Vogelmeier,Gerard J. Criner,Fernando J. Martinez,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Rongchang Chen,Marc Decramer,Leonardo M. Fabbri,Peter Frith,David M.G. Halpin,M. Victorina López Varela,Masaharu Nishimura,Nicolas Roche,Roberto Rodriguez-Roisin,Don D. Sin,Dave Singh,Robert Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Alvar Agusti +21 more
TL;DR: The assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation, and the concept of deescalation of therapy is introduced in the treatment assessment scheme.
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Dave Singh,Alvar Agusti,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Gerard J. Criner,Peter Frith,David M.G. Halpin,MeiLan K. Han,M. Victorina López Varela,Fernando J. Martinez,Maria Montes de Oca,Alberto Papi,Ian D. Pavord,Nicolas Roche,Don D. Sin,Robert A. Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Claus Vogelmeier +20 more
TL;DR: Blood eosinophils are recommended as a biomarker to support clinical decisions regarding the use of inhaled corticosteroids in chronic obstructive pulmonary disease patients, based on recent evidence from clinical trials.
Journal ArticleDOI
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Rembert Koczulla,Georges von Degenfeld,Christian Kupatt,Florian Krötz,Stefan Zahler,Torsten Gloe,Katja Issbrücker,Pia Unterberger,Mohamed Zaiou,Mohamed Zaiou,Corinna Lebherz,Alexander Karl,Philip Raake,Achim Pfosser,Peter Boekstegers,Ulrich Welsch,Pieter S. Hiemstra,Claus Vogelmeier,Richard L. Gallo,Richard L. Gallo,Matthias Clauss,Robert Bals,Robert Bals +22 more
TL;DR: It is demonstrated that LL-37/hCAP-18 is a multifunctional antimicrobial peptide with a central role in innate immunity by linking host defense and inflammation with angiogenesis and arteriogenesis.
Journal ArticleDOI
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Claus Vogelmeier,Gerard J. Criner,Fernando J. Martinez,Antonio Anzueto,Peter J. Barnes,Jean Bourbeau,Bartolome R. Celli,Rongchang Chen,Marc Decramer,Leonardo M. Fabbri,Peter Frith,David M.G. Halpin,M. Victorina López Varela,Masaharu Nishimura,Nicolas Roche,Roberto Rodriguez-Roisin,Don D. Sin,Dave Singh,Robert Stockley,Jørgen Vestbo,Jadwiga A. Wedzicha,Alvar Agusti +21 more
TL;DR: The assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation, and the concept of de-escalation of therapy is introduced in the treatment assessment scheme.